Multiple companies, including Eli Lilly, Amgen, Ionis, and Novartis, are developing advanced experimental drugs for heart disease, including those targeting Lp(a).
2 reports, 2 independent
Updated Sep 14
Gone quiet
- Reports
- 2
- Developments
- 9
- Repetition
- 0%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Multiple companies, including Eli Lilly, Amgen, Ionis, and Novartis, are developing advanced experimental drugs for heart disease, including those targeting Lp(a).
Who's involved
What this event is mainly aboutHow it developed
Newest first. Tap a step to see who reported it.Novartis licensed pelacarsen from Ionis, while multiple firms advance Lp(a) treatments.1 source
- Ionis Pharmaceuticals and Novartis co-developed heart drug Pelacarsen and are seeking regulatory approval for drug trials.Sub-event
- Amgen and Novartis have developed similar drugs aimed at treating heart conditions.Sub-event
- Pelacarsen Phase 3 trial failure involving Ionis Pharmaceuticals and Novartis.Sub-event
- Amgen benefits from Novartis/Ionis Phase 3 research, Mizuho raised price targets, and the company faces a tax dispute resolution timeline.Sub-event
- Eli Lilly acquired Verve Therapeutics, advancing one-time treatments for high cardiovascular risk.Sub-event
- Mineralys Therapeutics presented its clinical trial results at the American Heart Association sessions in Baltimore.Sub-event
- Novartis gains exclusive rights to develop ARO-SNCA through a collaboration that validates Arrowhead's TRiM technology.Sub-event
Show 1 earlier step
Companies are developing advanced experimental drugs for heart disease, informed by AHA guidelines and clinical practice.1 source
Keep exploring
The entities involved
-
Ionis Pharmaceuticals
American pharmaceutical company
-
Amgen
American multinational biopharmaceutical company
-
Novartis
Swiss-American multinational pharmaceutical corporation
-
Eli Lilly and Company
American pharmaceutical company